Your Messages Inbox
Your Article Summary
See Latest ArticlesFDA Accepts for Filing Mylans ANDA for Generic CopaxoneÂ
Mylan, 09/15/09
Mylan Inc. announced that the U.S. Food and Drug Administration has accepted for filing Mylan Pharmaceutical Inc.'s abbreviated new drug application for Glatiramer Acetate Injection, a generic version of Teva's Copaxone, a product indicated for the treatment of multiple sclerosis.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Ustekinumab (Stelara): First-in-class human monoclonal antibody approved for treatment of moderate-to-severe plaque psoriasis
Formulary , 12/02/09
Safety concerns slow new drug review and approval processes
Formulary , 12/02/09
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09
Article Search
Sponsor